LYRA
Lyra Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Carmichael S. Roberts Jr.
IPO Date
2020-05-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Lyra Therapeutics, Inc.
CEO
Carmichael S. Roberts Jr.
IPO Date
2020-05-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 2,000 |
| $0.00 |
| 3 Apr 2026 | Cavalier Jason | Principal Financial Officer | D-Return | Disposed | 667 | $0.00 |
| 8 Jan 2026 | Cavalier Jason | Chief Financial Officer | S-Sale | Disposed | 769 | $3.36 |
| 8 Jan 2026 | Palasis Maria | director, officer: President & CEO | S-Sale | Disposed | 1,702 | $3.36 |
| 13 Nov 2025 | PERCEPTIVE ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 4,783 | $4.31 |
| 13 Nov 2025 | PERCEPTIVE ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 537 | $4.31 |
| 13 Nov 2025 | PERCEPTIVE ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 7,862 | $4.06 |
| 13 Nov 2025 | PERCEPTIVE ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 883 | $4.06 |
| 13 Nov 2025 | PERCEPTIVE ADVISORS LLC | 10 percent owner | S-Sale | Disposed | 28,597 | $3.90 |